oleanolic acid has been researched along with Kidney Failure, Chronic in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (90.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capolongo, G; Celentano, S; Pollastro, RM | 1 |
| Block, GA; Chertow, GM; Chin, MP; Ferguson, DA; Goldsberry, A; Jadoul, M; Lewis, JH; Meyer, CJ; O'Grady, M; Pergola, PE; Reisman, SA; Wigley, WC | 1 |
| Bakris, GL; Block, GA; Chertow, GM; Chin, MP; Goldsberry, A; Heerspink, HJL; Inker, LA; Meyer, CJ; O'Grady, M; Pergola, PE; Wanner, C; Warnock, DG | 1 |
| Block, GA; Chertow, GM; Chin, MP; Goldsberry, A; Heerspink, HJL; McCullough, PA; Meyer, CJ; Packham, D; Pergola, PE; Rossing, P; Spinowitz, B; Sprague, SM; Warnock, DG | 1 |
| Himmelfarb, J; Tuttle, KR | 2 |
| Akizawa, T; Audhya, P; Bakris, GL; Chertow, GM; Chin, M; Christ-Schmidt, H; de Zeeuw, D; Goldsberry, A; Houser, M; Krauth, M; Lambers Heerspink, HJ; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D | 1 |
| Chertow, GM; de Zeeuw, D | 1 |
| Chartoumpekis, DV; Sykiotis, GP | 1 |
| Kovács, T; Molnár, GA; Wittmann, I | 1 |
| Ellison, DH | 1 |
| Van Biesen, W; Van Laecke, S; Vanholder, R | 1 |
| de Zeeuw, D; Meyer, C | 1 |
| Camer, D; Huang, XF | 1 |
| Ferguson, DA; Huff, JW; Krauth, M; Meyer, CJ; Pergola, PE; Ruiz, S; Warnock, DG | 1 |
| Cooper, ME; Thomas, MC | 1 |
| Abramowitz, MK; Bauer, C; Hostetter, TH; Melamed, ML; Turner, JM | 1 |
| Bargman, J; Burkart, J; Chertow, GM; Davies, S; Finkelstein, FO; Hebbar, S; Mehrotra, R; Ronco, C; Teitelbaum, I; Urakpo, K; Warnock, DG | 1 |
| Pergola, PE; Ruiz, S; Vaziri, ND; Zager, RA | 1 |
| Fujimoto, M; Hata, S; Kuroda, T; Mihara, S; Shimizu, T | 1 |
4 review(s) available for oleanolic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Bardoxolone: a new potential therapeutic agent in the treatment of autosomal dominant polycystic kidney disease?]
Topics: Clinical Trials as Topic; Disease Progression; Down-Regulation; Early Termination of Clinical Trials; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; Polycystic Kidney, Autosomal Dominant; Renal Agents | 2019 |
Treatment of chronic kidney disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus, Type 2; Disease Progression; Endothelin-1; Humans; Hypertension; Kidney Failure, Chronic; Oleanolic Acid; Pyridones; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Inflammation; Kidney Failure, Chronic; Oleanolic Acid; Peritoneal Dialysis; Prospective Studies; Research Design; Sample Size | 2012 |
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Antioxidants; Disease Progression; Humans; Inflammation; Kidney; Kidney Failure, Chronic; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2013 |
5 trial(s) available for oleanolic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation, Enzymologic; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Middle Aged; NF-E2-Related Factor 2; Oleanolic Acid | 2021 |
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
Topics: Aged; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Oleanolic Acid; Renal Dialysis; Treatment Outcome | 2018 |
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Topics: Adult; Albuminuria; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Early Termination of Clinical Trials; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oleanolic Acid; Treatment Outcome | 2019 |
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; NF-E2-Related Factor 2; Oleanolic Acid; Renal Insufficiency, Chronic; Treatment Failure; Weight Loss | 2013 |
Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD.
Topics: Adult; Aged; Antioxidants; Creatinine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Oleanolic Acid; Oxidative Stress; Placebos; Time Factors | 2011 |
11 other study(ies) available for oleanolic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
New therapies for diabetic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2013 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
The paradox of bardoxolone methyl: a call for every witness on the stand?
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2015 |
The paradox created by commenting on large clinical trial results.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2015 |
The endothelin pathway: a protective or detrimental target of bardoxolone methyl on cardiac function in patients with advanced chronic kidney disease?
Topics: Blood Pressure; Cardiovascular System; Clinical Trials, Phase III as Topic; Early Termination of Clinical Trials; Endothelins; Heart; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Oleanolic Acid | 2014 |
Diabetes: bardoxolone improves kidney function in type 2 diabetes.
Topics: Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Inactivation, Metabolic; Kidney Failure, Chronic; NF-E2-Related Factor 2; Oleanolic Acid | 2011 |
Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
Topics: Animals; Caffeic Acids; Creatine; Down-Regulation; Endothelin Receptor Antagonists; Endothelins; Kidney; Kidney Failure, Chronic; Male; Nephrectomy; Oleanolic Acid; Protein Precursors; Proteinuria; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Sulfonamides | 1999 |